This federal Project Grant award in the amount of $316,250.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The funding supports a research project to investigate a new class of neurosteroids called steroid phosphodiesters (SPEDs) conducted by Coddle Creek Capital, LLC in Kannapolis, North Carolina. The award has a performance period from February 1, 2025 to January 31, 2027. The Military Medical Research and Development program funds a range of biomedical research initiatives aimed at improving health outcomes for military service members, veterans, and the broader public, spanning areas such as cancer, neurological disorders, and emerging medical technologies. This specific project seeks to advance the scientific understanding of this novel class of neurosteroids and their potential therapeutic applications.
Generated 3/4/25, 7:32 AM